GC32625
KDR-in-4
Also known as 3-[5-[2-[2-methoxyethyl(methyl)amino]ethoxy]-1H-indol-2-yl]-1H-quinolin-2-one
KDR-in-4 (KDR-in-4) is a potent kinase insert domain-containing receptor (KDR/VEGFR2) inhibitor with an IC50 of 7 nM
ChemicalCAS408502-06-7MW391.46FormulaC23H25N3O3
- CAS number
- 408502-06-7
- Molecular weight
- 391.46
- Formula
- C23H25N3O3
- Solubility
- Soluble in DMSO
- InChIKey
- IVKQYQMLUAZKPB-UHFFFAOYSA-N
- Catalogue number
- GC32625
- Brand
- GLPBIO
Computed properties PubChem CID 5329372 · XLogP 3 · TPSA 66.6 Ų · H-bond donors 2
- XLogP
- 3
- TPSA
- 66.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Rotatable bonds
- 8
- Heavy atoms
- 29
SMILES CN(CCOC)CCOC1=CC2=C(C=C1)NC(=C2)C3=CC4=CC=CC=C4NC3=O
Computed descriptors from PubChem (CID 5329372), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il